NASAL SPRAY SWINE FLU VACCINE

By Jon Rappoport

It’s been confirmed that the first doses of Swine Flu vaccine will be nasal spray.

Here is a clip from the LA Times:

By Thomas H. Maugh II ........September 19, 2009

At least 3.4 million doses of vaccine against the pandemic H1N1 influenza virus will be available at the beginning of October, and about 20 million doses per week should become available soon after that, federal officials said Friday.

The first vaccine available will be MedImmune's FluMist intranasal vaccine, but injectable vaccines should be distributed a week or two later, Dr. Jay Butler, chief of the Centers for Disease Control and Prevention's 2009 H1N1 vaccine task force, said at a morning news conference. The intranasal vaccine has not been approved for children younger than 2, adults older than 49 or pregnant women, so it may go primarily to healthcare providers.

End of LA Times clip.

Note that the FDA has not approved the nasal spray vaccine for:

Children under 2;

Adults older than 49;

Pregnant women.

Why not?

What’s in the vaccine?

Dr. Sherri Tenpenny points out that putting a vaccine into the body through the nasal cavity brings the contents of the vaccine dangerously close to the brain.

Although this vaccine is supposed to contain inactivated H1N1 virus, there have been instances in which inactivation was botched in the manufacturing process of other vaccines. Therefore, the virus was able to cause infection and illness.

And here is another explosive issue---

The Times article mentions that health workers will likely be the first people to receive this nasal-spray vaccine.

Dr. Tenpenny states that the package-insert for past FluMist vaccines warns, “FluMist recipients should avoid close contact with immunocompromised individuals for at least 21 days.”

Where would health workers be likely to encounter such individuals? IN THE HOSPITAL.

So this nasal spray will be shedding and spreading virus among debilitated and immune-system-weakened patients in hospitals.

And of course, there are millions of people everywhere whose immune systems are weak.

Finally, why would the manufacturer of this vaccine want people who take the vaccine to avoid contact with immunocompromised individuals, IF THE VIRUS IN THE VACCINE IS INACTIVATED AND HARMLESS.

Think about that.

One doctor I’ve spoken to said, “No. The virus in the vaccine won’t spread to people with weak immune systems. But the virus could stimulate their immune systems, which are already weak, and therefore overload them, causing serious problems.”

Really?

Well, even in that case, the conclusion would be: ANYONE WHO HAS A WEAK IMMUNE SYSTEM shouldn’t take the vaccine in the first place. And public health agencies aren’t issuing broad warnings about that.

No matter how you look at it, the FluMist vaccine is set to cause some major problems as it rolls out from the manufacturer.

Those health workers who are protesting against mandatory Swine Flu vaccination in New York for themselves should understand these issues.

JON RAPPOPORT